Huang, Y., Kwan, M. L., Heckbert, S. R., Smith, N. L., Othus, M., Laurent, C. A., Roh, J. M., Rillamas-Sun, E., Lee, V. S., Kolevska, T., Cheng, R. K., Irribarren, C., Nguyen-Huynh, M., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2025). Endocrine therapy and risk of cardiovascular disease and mortality in postmenopausal breast cancer survivors. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf063

Zhao, J., Kajeepeta, S., Manz, C. R., Han, X., Nogueira, L. M., Zheng, Z., Fan, Q., Shi, K. S., Chino, F., & Yabroff, K. R. (2024). County-level jail and state-level prison incarceration and cancer mortality in the United States. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae189

Serrano, D., Johansson, H., Bertelsen, B.-E., Gandini, S., Mellgren, G., Thomas, P., Crew, K. D., Kumar, N. B., Macis, D., Aristarco, V., Guerrieri-Gonzaga, A., Lazzeroni, M., D’Amico, M., Buttiron-Webber, T., Briata, I. M., Spinaci, S., Galimberti, V., Vornik, L. A., Villar-Sanchez, E., … DeCensi, A. (2024). Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae183

Wolfson, J. A., Davis, E. S., Saha, A., Martinez, I., McCall, D., Kothari, P., Brackett, J., Dickens, D. S., Kahn, A. R., Schwalm, C., Sharma, A., Richman, J., Cuglievan, B., Bhatia, S., Dai, C., Levine, J. M., & Johnston, E. E. (2024). Adolescents and young adults with cancer: the clinical course of COVID-19 infections. JNCI: Journal of the National Cancer Institute, 116(8), 1366–1373. https://doi.org/10.1093/jnci/djae085

Basu, A., & Hershman, D. L. (2024). The “PRO”mise and “PRO”gress of PROs in cancer clinical trials. JNCI: Journal of the National Cancer Institute, 116(10), 1544–1546. https://doi.org/10.1093/jnci/djae157

Kehm, R. D. (2024). Continued prioritization of biomedical research over sociomedical research may widen disparities in cancer outcomes. JNCI: Journal of the National Cancer Institute, 116(10), 1547–1548. https://doi.org/10.1093/jnci/djae150

Berkman, A. M., Betts, A. C., Beauchemin, M., Parsons, S. K., Freyer, D. R., & Roth, M. E. (2024). Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae119

Suzuki, Y., Ferris, J. S., Chen, L., Dioun, S., Usseglio, J., Matsuo, K., Xu, X., Hershman, D. L., & Wright, J. D. (2024). Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis. JNCI: Journal of the National Cancer Institute, 116(5), 653–664. https://doi.org/10.1093/jnci/djae023

Jones, R. R., Madrigal, J. M., Troisi, R., Surcel, H.-M., Öhman, H., Kivelä, J., Kiviranta, H., Rantakokko, P., Koponen, J., Medgyesi, D. N., McGlynn, K. A., Sampson, J., Albert, P. S., & Ward, M. H. (2023). Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia. JNCI: Journal of the National Cancer Institute, 116(5), 728–736. https://doi.org/10.1093/jnci/djad261

Rusthoven, C. G., Staley, A. W., Gao, D., Yomo, S., Bernhardt, D., Wandrey, N., El Shafie, R., Kraemer, A., Padilla, O., Chiang, V., Faramand, A. M., Palmer, J. D., Zacharia, B. E., Wegner, R. E., Hattangadi-Gluth, J. A., Levy, A., Bernstein, K., Mathieu, D., Cagney, D. N., … Yamamoto, M. (2023). Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE). JNCI: Journal of the National Cancer Institute, 115(8), 926–936. https://doi.org/10.1093/jnci/djad073

Viragova, S., Aparicio, L., Palmerini, P., Zhao, J., Valencia Salazar, L. E., Schurer, A., Dhuri, A., Sahoo, D., Moskaluk, C. A., Rabadan, R., & Dalerba, P. (2023). Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma. JNCI: Journal of the National Cancer Institute, 115(7), 838–852. https://doi.org/10.1093/jnci/djad062

Xu, X., Chen, L., Nunez-Smith, M., Clark, M., & Wright, J. D. (2023). Racial disparities in diagnostic evaluation of uterine cancer among Medicaid beneficiaries. JNCI: Journal of the National Cancer Institute, 115(6), 636–643. https://doi.org/10.1093/jnci/djad027

Jim, H. S. L., Brady-Nicholls, R., & Hershman, D. L. (2023). The importance of patient-reported outcomes in pragmatic clinical trials. JNCI: Journal of the National Cancer Institute, 115(4), 352–354. https://doi.org/10.1093/jnci/djad037

Ma, W., Walker, M. M., Thuresson, M., Roelstraete, B., Sköldberg, F., Olén, O., Strate, L. L., Chan, A. T., & Ludvigsson, J. F. (2022). Cancer risk in patients with diverticular disease: A nationwide cohort study. JNCI: Journal of the National Cancer Institute, 115(1), 62–70. https://doi.org/10.1093/jnci/djac190

Cogan, J. C., Raghunathan, R. R., Beauchemin, M. P., Accordino, M. K., Huang, Y., Elkin, E. B., Melamed, A., Wright, J. D., & Hershman, D. L. (2022). New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer. JNCI: Journal of the National Cancer Institute, 114(12), 1698–1705. https://doi.org/10.1093/jnci/djac170

Hawley, J. E., Pan, S., Kandadi, H., Chaimowitz, M. G., Sheikh, N., & Drake, C. G. (2021). Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T. JNCI: Journal of the National Cancer Institute, 114(2), 314–317. https://doi.org/10.1093/jnci/djab145